Antivirals for treatment of HIV infections, combinations J05AR

J05AR01

zidovudine and lamivudine

-

J05AR02

lamivudine and abacavir

-

J05AR03

tenofovir disoproxil and emtricitabine

-

J05AR04

zidovudine, lamivudine and abacavir

-

J05AR05

zidovudine, lamivudine and nevirapine

-

J05AR06

emtricitabine, tenofovir disoproxil and efavirenz

-

J05AR07

stavudine, lamivudine and nevirapine

-

J05AR08

emtricitabine, tenofovir disoproxil and rilpivirine

-

J05AR09

emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat

-

J05AR10

lopinavir and ritonavir

-

J05AR11

lamivudine, tenofovir disoproxil and efavirenz

-

J05AR12

lamivudine and tenofovir disoproxil

-

J05AR13

lamivudine, abacavir and dolutegravir

-

J05AR14

darunavir and cobicistat

-

J05AR15

atazanavir and cobicistat

-

J05AR16

lamivudine and raltegravir

-

J05AR17

emtricitabine and tenofovir alafenamide

-

J05AR18

emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat

-

J05AR19

emtricitabine, tenofovir alafenamide and rilpivirine

-

J05AR20

emtricitabine, tenofovir alafenamide and bictegravir

-

J05AR21

dolutegravir and rilpivirine

-

J05AR22

emtricitabine, tenofovir alafenamide, darunavir and cobicistat

-

J05AR23

atazanavir and ritonavir

-

J05AR24

lamivudine, tenofovir disoproxil and doravirine

-

J05AR25

lamivudine and dolutegravir

-

J05AR26

darunavir and ritonavir

-

J05AR27

lamivudine, tenofovir disoproxil and dolutegravir

-

J05AR28

stavudine and lamivudine

-